These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20371623)

  • 1. Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.
    Theodoropoulou S; Kolovou PE; Morizane Y; Kayama M; Nicolaou F; Miller JW; Gragoudas E; Ksander BR; Vavvas DG
    FASEB J; 2010 Aug; 24(8):2620-30. PubMed ID: 20371623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uveal melanoma cell growth is inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.
    Al-Moujahed A; Nicolaou F; Brodowska K; Papakostas TD; Marmalidou A; Ksander BR; Miller JW; Gragoudas E; Vavvas DG
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(7):4175-85. PubMed ID: 24781943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosis.
    Theodoropoulou S; Brodowska K; Kayama M; Morizane Y; Miller JW; Gragoudas ES; Vavvas DG
    PLoS One; 2013; 8(1):e52852. PubMed ID: 23300996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMP-activated protein kinase is involved in neural stem cell growth suppression and cell cycle arrest by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and glucose deprivation by down-regulating phospho-retinoblastoma protein and cyclin D.
    Zang Y; Yu LF; Nan FJ; Feng LY; Li J
    J Biol Chem; 2009 Mar; 284(10):6175-84. PubMed ID: 19144636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
    Rattan R; Giri S; Singh AK; Singh I
    J Biol Chem; 2005 Nov; 280(47):39582-93. PubMed ID: 16176927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
    Zhuge J
    Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of AMP-kinase by AICAR induces apoptosis of DU-145 prostate cancer cells through generation of reactive oxygen species and activation of c-Jun N-terminal kinase.
    Sauer H; Engel S; Milosevic N; Sharifpanah F; Wartenberg M
    Int J Oncol; 2012 Feb; 40(2):501-8. PubMed ID: 22002081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.
    Igata M; Motoshima H; Tsuruzoe K; Kojima K; Matsumura T; Kondo T; Taguchi T; Nakamaru K; Yano M; Kukidome D; Matsumoto K; Toyonaga T; Asano T; Nishikawa T; Araki E
    Circ Res; 2005 Oct; 97(8):837-44. PubMed ID: 16151020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.
    Choi HJ; Kim TY; Chung N; Yim JH; Kim WG; Kim JA; Kim WB; Shong YK
    J Endocrinol; 2011 Oct; 211(1):79-85. PubMed ID: 21795305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells.
    Kim WG; Choi HJ; Kim TY; Shong YK; Kim WB
    Korean J Intern Med; 2014 Jul; 29(4):474-81. PubMed ID: 25045295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells.
    Baumann P; Mandl-Weber S; Emmerich B; Straka C; Schmidmaier R
    Exp Cell Res; 2007 Oct; 313(16):3592-603. PubMed ID: 17669398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of AMP-activated protein kinase inhibits the proliferation of human endothelial cells.
    Peyton KJ; Liu XM; Yu Y; Yates B; Durante W
    J Pharmacol Exp Ther; 2012 Sep; 342(3):827-34. PubMed ID: 22700432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation.
    Ishii N; Matsumura T; Kinoshita H; Motoshima H; Kojima K; Tsutsumi A; Kawasaki S; Yano M; Senokuchi T; Asano T; Nishikawa T; Araki E
    J Biol Chem; 2009 Dec; 284(50):34561-9. PubMed ID: 19843515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMP-activated protein kinase activation by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) inhibits palmitate-induced endothelial cell apoptosis through reactive oxygen species suppression.
    Kim JE; Kim YW; Lee IK; Kim JY; Kang YJ; Park SY
    J Pharmacol Sci; 2008 Mar; 106(3):394-403. PubMed ID: 18360094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.
    Imamura K; Ogura T; Kishimoto A; Kaminishi M; Esumi H
    Biochem Biophys Res Commun; 2001 Sep; 287(2):562-7. PubMed ID: 11554766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside is independent of AMP-activated protein kinase activation.
    Jacobs RL; Lingrell S; Dyck JRB; Vance DE
    J Biol Chem; 2007 Feb; 282(7):4516-4523. PubMed ID: 17179149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
    Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
    Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
    Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.